Vittorio Albertazzi Selected Research

Vittorio Albertazzi Research Topics

3	Proteinuria 05/2022 - 12/2012
2	Inflammation (Inflammations) 01/2016 - 07/2015
2	Chronic Renal Insufficiency 01/2016 - 12/2012
1	Sclerosis 05/2022
1	COVID-19 01/2021
1	Infections 01/2016
1	Amyloidosis 07/2015
1	Conjunctivitis 07/2015
1	Urticaria (Hives) 07/2015
1	Arthralgia (Joint Pain) 07/2015
1	Cryopyrin-Associated Periodic Syndromes 07/2015
1	Neoplasms (Cancer) 12/2012
1	Pancreatitis 12/2012
1	Myalgia 12/2012
1	Heart Failure 12/2012
1	Hepatitis 12/2012
1	Coronary Disease (Coronary Heart Disease) 12/2012
1	Rhabdomyolysis 12/2012
1	Gallstones (Gallstone) 12/2012
1	Cardiac Arrhythmias (Arrythmia) 12/2012
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2012
1	Dyslipidemias (Dyslipidemia) 12/2012
1	Hemolytic-Uremic Syndrome 11/2010
1	Macular Degeneration (Age-Related Maculopathy) 11/2010
1	Disease Progression 11/2010
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 11/2010

1	Antihypertensive Agents (Antihypertensives)IBA 05/2022
1	AldosteroneIBA 05/2022
1	Losartan (Cozaar)FDA LinkGeneric 05/2022
1	CreatinineIBA 01/2021
1	CytokinesIBA 01/2016
1	NLR ProteinsIBA 01/2016
1	InflammasomesIBA 01/2016
1	Monoclonal AntibodiesIBA 07/2015
1	AA amyloidosisIBA 07/2015
1	canakinumab FDA Link 07/2015
1	Amyloid (Amyloid Fibrils)IBA 07/2015
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2015
1	LipidsIBA 12/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2012
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2012
1	CholesterolIBA 12/2012
1	Complement System Proteins (Complement)IBA 11/2010

4	Therapeutics 05/2022 - 11/2010
1	Contraindications 11/2010